# A Trial of LY3056480 in Patients With SNLH

> **NCT05061758** · PHASE2 · WITHDRAWN · sponsor: **Audion Therapeutics BV**

## Conditions studied

- Sensorineural Hearing Loss

## Interventions

- **DRUG:** LY3056480

## Key facts

- **NCT ID:** NCT05061758
- **Lead sponsor:** Audion Therapeutics BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-09
- **Primary completion:** 2024-09
- **Final completion:** 2025-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study put on hold
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05061758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05061758, "A Trial of LY3056480 in Patients With SNLH". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05061758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*